These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28978174)

  • 1. Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Kim YJ; Byun SJ; Ahn H; Kim CS; Hong BS; Yoo S; Lee JL; Kim YS
    Oncotarget; 2017 Sep; 8(40):68996-69004. PubMed ID: 28978174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Malek R; Kübler H; Stenzl A; Gakis G
    Urol Oncol; 2018 Feb; 36(2):43-53. PubMed ID: 29102254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
    Arcangeli G; Strigari L; Arcangeli S
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):387-96. PubMed ID: 25934521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after sequential neoadjuvant chemotherapy followed by trimodal treatment or radical cystectomy for muscle-invasive bladder cancer.
    Reignier PL; Gauthier H; Hennequin C; Aussedat Q; Xylinas E; Desgrandchamps F; Culine S; Masson-Lecomte A; Dumont C
    World J Urol; 2023 Nov; 41(11):3249-3255. PubMed ID: 37410102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis.
    Su X; Dong C; Liao W; Liu W
    World J Surg Oncol; 2023 Aug; 21(1):271. PubMed ID: 37641150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: Single-center experience.
    Fallatah M; Alkahtani AS; Alrumayyan M; Alotaibi MF; Alkhateeb S; Mokhtar AA; Altaweel W
    Urol Ann; 2023; 15(4):406-411. PubMed ID: 38074180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.
    Kumar A; Cherry DR; Courtney PT; Nalawade V; Kotha N; Riviere PJ; Efstathiou J; McKay RR; Karim Kader A; Rose BS; Stewart TF
    Eur Urol Open Sci; 2021 Aug; 30():1-10. PubMed ID: 34337540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
    Mak KS; Smith AB; Eidelman A; Clayman R; Niemierko A; Cheng JS; Matthews J; Drumm MR; Nielsen ME; Feldman AS; Lee RJ; Zietman AL; Chen RC; Shipley WU; Milowsky MI; Efstathiou JA
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1028-1036. PubMed ID: 27727064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis.
    Ding H; Fan N; Ning Z; Ma D
    Front Oncol; 2020; 10():564779. PubMed ID: 33154943
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis.
    Qiu J; Zhang H; Xu D; Li L; Xu L; Jiang Y; Wen T; Lu S; Meng F; Feng L; Shu X
    J Oncol; 2022; 2022():7306198. PubMed ID: 35607328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
    Mathieu R; Lucca I; Klatte T; Babjuk M; Shariat SF
    Curr Opin Urol; 2015 Sep; 25(5):476-82. PubMed ID: 26125510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodal therapy in muscle invasive bladder cancer management.
    Polo-Alonso E; Kuk C; Guruli G; Paul AK; Thalmann G; Kamat A; Solsona E; Thalmann G; Urdaneta AI; Zlotta AR; Mir MC
    Minerva Urol Nefrol; 2020 Dec; 72(6):650-662. PubMed ID: 33263367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Royce TJ; Feldman AS; Mossanen M; Yang JC; Shipley WU; Pandharipande PV; Efstathiou JA
    Clin Genitourin Cancer; 2019 Feb; 17(1):23-31.e3. PubMed ID: 30482661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy.
    El-Achkar A; Souhami L; Kassouf W
    Curr Urol Rep; 2018 Nov; 19(12):108. PubMed ID: 30392150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer.
    Witjes JA; Feikema AAH
    Cancer Manag Res; 2021; 13():7833-7839. PubMed ID: 34675678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
    Golla V; Shan Y; Farran EJ; Stewart CA; Vu K; Yu A; Khaki AR; Parikh DA; Swanson TA; Keegan KA; Kamat AM; Tyler DS; Freedland SJ; Williams SB
    Urol Oncol; 2022 Jun; 40(6):273.e1-273.e9. PubMed ID: 35168881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Outcomes Between Radical Radiotherapy and Radical Cystectomy in Muscle Invasive Bladder Cancer in a Cancer Specialized Unit of a Developing Country.
    Fiaz S; Ali A; Adnan S; Khalil MAI; Rasheed Y; Abu Bakar M; Ahmad Cheema Z; Mir K
    Cureus; 2020 Aug; 12(8):e10057. PubMed ID: 32999780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer.
    Tholomier C; Souhami L; Kassouf W
    Transl Androl Urol; 2020 Dec; 9(6):2920-2937. PubMed ID: 33457265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.